PolyPid (PYPD) Total Debt (2022 - 2026)
PolyPid (PYPD) posted Total Debt of $801000.0 for Q1 2026, down 18.93% sequentially from $988000.0 in Q4 2025, and down 88.36% YoY from $6.9 million in Q1 2025.
PolyPid (PYPD) Total Debt (2022 - 2026) Analysis & Trends
PolyPid has reported Total Debt for 5 years, with the latest figure at $801000.0 in Q1 2026.
- Quarterly Total Debt fell 88.36% year-over-year to $801000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $801000.0 (down 88.36% YoY) and the FY2025 annual result came in at $988000.0, down 86.69% from the prior year.
- Total Debt retreated to $801000.0 in Q1 2026 per PYPD's latest filing, from $988000.0 in the prior quarter.
- Over five years, Total Debt peaked at $11.6 million in Q4 2022 and troughed at $801000.0 in Q1 2026.
- A 5-year average of $7.8 million and a median of $8.6 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2026: Total Debt advanced 16.72% in 2023, then slumped 88.36% in 2026.
- Over 5 years, Total Debt stood at $11.6 million in 2022, then slipped by 10.48% to $10.4 million in 2023, then fell by 28.52% to $7.4 million in 2024, then slumped by 86.69% to $988000.0 in 2025, then retreated by 18.93% to $801000.0 in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $801000.0, $988000.0, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | PolyPid | 113.30 Mn | 106.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 801,000.00 |
| Dec 31, 2025 | 988,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 6.55 Mn |
| Mar 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 7.42 Mn |
| Sep 30, 2024 | 7.71 Mn |
| Jun 30, 2024 | 8.56 Mn |
| Mar 31, 2024 | 8.72 Mn |
| Dec 31, 2023 | 10.38 Mn |
| Sep 30, 2023 | 10.52 Mn |
| Jun 30, 2023 | 10.61 Mn |
| Mar 31, 2023 | 10.97 Mn |
| Dec 31, 2022 | 11.60 Mn |
| Sep 30, 2022 | 11.49 Mn |
| Jun 30, 2022 | 9.09 Mn |